Skip to main
AMIX
AMIX logo

AMIX Earnings Dates & Reports

AMIX Most Recent Earnings

Report DateMay 29, 2025
Period EndingQ4 2025
Est. EPS-$1.24
Actual EPS-$0.74
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

AMIX Earnings per Share (EPS) History

Signup for full access
Browse free

AMIX Latest Earnings

The value each AMIX share was expected to gain vs. the value each share gained.

AMIX reported its most recent earnings on May 29, 2025 for Q4 2025, posting earnings per share (EPS) of -$0.74. This exceeded analysts' expectations of -$1.24 by 40.32%, marking a Beat.

For comparison, Autonomix Medical Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 08/15/2025, with analysts projecting an EPS of $0.

AMIX Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2026Aug 15, 2025
Next earnings call Aug. 15, 2025
Q4 2025May 29, 2025
-$1.24-$0.74-40.32%
DeckReportListen

AMIX Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Autonomix Medical Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 29, 2025

AMIX Earnings FAQs

AMIX last reported earnings on May 29, 2025 for Q4 2025, posting an EPS of -$0.74, which Beat the estimate of -$1.24 by 40.32%.

For Q4 2025, AMIX reported an EPS of -$0.74, exceeding analysts' estimate of -$1.24 by 40.32%.

For Q4 2025, AMIX Beat expectations with an actual EPS of -$0.74 vs. an estimated EPS of -$1.24.

Following the last earnings report on May 29, 2025, AMIX's stock price moved — from — to —.

The next AMIX earnings call is scheduled for Aug. 15, 2025, where executives will discuss financial results and outlook.

Autonomix Medical Inc (AMIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.